Adverse drug reactions (ADRs) are a critical concern in healthcare, often leading to patient harm and increased healthcare costs. Despite the widespread implementation of clinical decision
READ MORE
The increasing availability of complex health data, coupled with advancing computational capabilities, offers an opportunity to define health and disease states with greater clarity and efficiency....
READ MORE
The utilisation of medical imaging has witnessed a remarkable surge in the past decade, accompanied by a concerning rise in inappropriate referrals for imaging procedures. In a bid to addres
READ MORE
Existing clinical decision support systems (CDSSs) designed to prevent drug-drug interaction (DDI) often generate low-yield alerts, leading to alert fatigue among physicians and jeopardising patient...
READ MORE
A new app-based service is set to go from strength to strength as it transitions to a national programme in support of the NHS and social care workforce, says InnoScot Health The Right Dec
READ MORE
Detailed Study of Clinical Decision Support Systems Market (2023-2030) Diving into the depths of the Global Market, the Clinical Decision Support Systems Market report offers a comprehensi
READ MORE
From wearable devices to artificial intelligence, the health care world has seen a boom in new digital health technologies. But while these new robotic medical assistants are exciting, they are only...
READ MORE
The 2013/59/Euratom guidance mandates suitable documentation and quality assurance systems for all systems using ionising radiation. This regulation commonly applies to radiology departments in the...
READ MORE
Traditionally, the use of healthcare services begins with an in-person appointment with a primary care physician, but being seen often takes days or weeks. As a consequence of the evolution of inform
READ MORE
A study published in Journal of Palliative Medicine describes the development and testing of a decision support system for palliative care based on pharmacogenomics. Pharmacogenomics des
READ MORE
